# Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients

> **NCT03015259** · PHASE3 · COMPLETED · sponsor: **Kindeva Drug Delivery** · enrollment: 1762 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/Formoterol fumarate dihydrate
- **DRUG:** Symbicort
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03015259
- **Lead sponsor:** Kindeva Drug Delivery
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-29
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-02-08
- **Target enrollment:** 1762 (ACTUAL)
- **Last updated:** 2022-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015259, "Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03015259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*